Analysts Set Axcelis Technologies, Inc. (NASDAQ:ACLS) PT at $130.25

Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) have been assigned a consensus recommendation of “Hold” from the six research firms that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $130.25.

Several equities research analysts have issued reports on the company. Bank of America lifted their price objective on Axcelis Technologies from $130.00 to $156.00 and gave the stock an “underperform” rating in a report on Tuesday, June 23rd. B. Riley Financial raised shares of Axcelis Technologies from a “neutral” rating to a “buy” rating and set a $150.00 price target for the company in a research report on Monday, April 20th. Zacks Research raised shares of Axcelis Technologies from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. Finally, Weiss Ratings downgraded shares of Axcelis Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Tuesday, May 12th.

Insider Buying and Selling

In other news, EVP Eileen Evans sold 926 shares of the stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $155.51, for a total transaction of $144,002.26. Following the transaction, the executive vice president owned 31,295 shares of the company’s stock, valued at approximately $4,866,685.45. This trade represents a 2.87% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Gerald M. Blumenstock sold 1,161 shares of Axcelis Technologies stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $152.70, for a total value of $177,284.70. Following the completion of the transaction, the executive vice president owned 20,493 shares of the company’s stock, valued at $3,129,281.10. This trade represents a 5.36% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 34,795 shares of company stock worth $5,344,383. 0.49% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Axcelis Technologies

Institutional investors have recently made changes to their positions in the company. Victory Capital Management Inc. lifted its stake in Axcelis Technologies by 85.9% during the fourth quarter. Victory Capital Management Inc. now owns 1,807,404 shares of the semiconductor company’s stock worth $145,207,000 after purchasing an additional 835,242 shares during the last quarter. The Manufacturers Life Insurance Company boosted its holdings in Axcelis Technologies by 3,402.5% in the first quarter. The Manufacturers Life Insurance Company now owns 491,745 shares of the semiconductor company’s stock worth $45,772,000 after purchasing an additional 477,705 shares during the period. Invesco Ltd. boosted its holdings in Axcelis Technologies by 176.6% in the third quarter. Invesco Ltd. now owns 386,735 shares of the semiconductor company’s stock worth $37,761,000 after purchasing an additional 246,939 shares during the period. Balyasny Asset Management L.P. increased its stake in Axcelis Technologies by 10,368.7% during the fourth quarter. Balyasny Asset Management L.P. now owns 243,503 shares of the semiconductor company’s stock valued at $19,563,000 after purchasing an additional 241,177 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC increased its stake in Axcelis Technologies by 142.7% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 266,015 shares of the semiconductor company’s stock valued at $22,909,000 after purchasing an additional 156,387 shares during the last quarter. 89.98% of the stock is currently owned by institutional investors.

Axcelis Technologies Stock Performance

Axcelis Technologies stock opened at $144.50 on Friday. Axcelis Technologies has a 12-month low of $65.64 and a 12-month high of $193.78. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.59 and a quick ratio of 2.99. The company has a market capitalization of $4.44 billion, a price-to-earnings ratio of 45.02, a price-to-earnings-growth ratio of 10.23 and a beta of 1.88. The firm’s fifty day moving average price is $160.73 and its 200 day moving average price is $115.88.

Axcelis Technologies (NASDAQ:ACLS) last posted its quarterly earnings data on Thursday, May 7th. The semiconductor company reported $0.72 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. The company had revenue of $198.96 million during the quarter, compared to analysts’ expectations of $195.03 million. Axcelis Technologies had a net margin of 11.93% and a return on equity of 12.19%. The firm’s revenue for the quarter was up 3.3% on a year-over-year basis. During the same period in the prior year, the company posted $0.88 EPS. Axcelis Technologies has set its Q2 2026 guidance at 0.900- EPS. On average, research analysts forecast that Axcelis Technologies will post 3.21 EPS for the current fiscal year.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.